Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immucell (ICCC) Interest Expenses (2016 - 2025)

Immucell (ICCC) has disclosed Interest Expenses for 12 consecutive years, with $134516.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Expenses fell 6.68% year-over-year to $134516.0, compared with a TTM value of $134516.0 through Sep 2025, down 68.9%, and an annual FY2023 reading of $475598.0, up 36.46% over the prior year.
  • Interest Expenses was $134516.0 for Q3 2025 at Immucell, down from $144141.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $146003.0 in Q1 2024 and bottomed at $88577.0 in Q2 2023.
  • Average Interest Expenses over 3 years is $124267.7, with a median of $138450.5 recorded in 2024.
  • The sharpest move saw Interest Expenses soared 62.25% in 2024, then decreased 6.68% in 2025.
  • Year by year, Interest Expenses stood at $88577.0 in 2023, then skyrocketed by 62.73% to $144141.0 in 2024, then fell by 6.68% to $134516.0 in 2025.
  • Business Quant data shows Interest Expenses for ICCC at $134516.0 in Q3 2025, $144141.0 in Q3 2024, and $142385.0 in Q2 2024.